Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients

Transplantation

Volumn 92, Issue 5, 2011, Pages 581-586

  Lee, Victoria S ^a   Miller, Frank H ^a   Omary, Reed A ^a   Wang, Yi ^b   Ganger, Daniel R ^a   Wang, Edward ^a   Rao, Sambasiva ^a   Levitsky, Josh ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Hepatic fibrosis; Hepatitis C virus; Liver biopsy; Liver transplantation; Noninvasive tests

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE TO ALANINE AMINOTRANSFERASE RATIO; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; FIBROSPECTII; HEPATITIS C; HEPATOBILIARY PARAMETERS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAGNETIC RESONANCE ELASTOGRAPHY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; RECURRENCE;

EID: 80052402339     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822805fa     Document Type: Article

References (36)

1. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666.
2. Burra P. Hepatitis C. Semin Liver Dis 2009; 29: 53.
3. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553.
4. Gutkowski K, Hartleb M. Usefulness of non-invasive tools in liver fibrosis assessment. Hepatitis Monthly 2008; 8: 45.
5. Gilmore IT, Burroughs A, Murray-Lyon IM, et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: An audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36: 437.
6. Bravo AA, Sheth SG, Chopra S. Liver biopsy.NEngl J Med 2001; 344: 495.
7. Bedossa P, DargèreD, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449.
8. Goldin RD, Goldin JG, Burt AD, et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649.
9. Toniutto P, Fabris C, Bitetto D, et al. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 2007; 22: 1904.
10. Christensen C, Bruden D, Livingston S, et al. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients. J Viral Hepat 2006; 13: 652.
11. Zaman A, Rosen HR, Ingram K, et al. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Am J Med 2007; 120: 280.e9.
12. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elastography: Non-invasive mapping of tissue elasticity. Med Image Anal 2001; 5: 237.
13. Beckebaum S, Iacob S, Klein CG, et al. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients. Transplantation 2010; 89: 983.
14. Sánchez-Conde M, Montes-Ramírez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010; 17: 280.
15. Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009; 16: 300.
16. Carrión JA, Navasa M, Bosch J, et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791.
17. Carrión JA, Torres F, Crespo G, et al. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology 2010; 51: 23.
18. Corradi F, Piscaglia F, Flori S, et al. Assessment of liver fibrosis in transplant recipients with recurrentHCVinfection: Usefulness of transient elastography. Dig Liver Dis 2009; 41: 217.
19. Harada N, Soejima Y, Taketomi A, et al. Assessment of graft fibrosis by transient elastography in patients with recurrent hepatitis C after living donor liver transplantation. Transplantation 2008; 85: 69.
20. Forestier J, Dumortier J, Guillaud O, et al. Noninvasive diagnosis and prognosis of liver cirrhosis: A comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol 2010; 22: 532.
21. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: Preliminary results. Radiology 2006; 240: 440.
22. Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications. Hepatology 2008; 47: 332.
23. Bonekamp S, Kamel I, Solga S, et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009; 50: 17.
24. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207.
25. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: Noninvasive assessment withMRelastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007; 245: 458.
26. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008; 135: 32.
27. Berenguer M, Aguilera V, Prieto M, et al. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: Impact of donor age and baseline cirrhosis. Liver Transpl 2009; 15: 738.
28. Chalasani N, Manzarbeitia C, Ferenci P, et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials. Hepatology 2005; 41: 289.
29. Levitsky J, Doucette K. Viral hepatitis in solid organ transplant recipients. Am J Transplant 2009; 9: S116.
30. Carrión JA, Fernández-Varo G, Bruguera M, et al. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation. Gastroenterology 2010; 138: 147.
31. Blasco A, Forns X, Carrión JA, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006; 43: 492.
32. Kamphues C, Lotz K, Röcken C, et al. Chances and limitations of noninvasive tests in the assessment of liver fibrosis in liver transplant patients. Clin Transplant 2009; 24: 652.
33. National Cholesterol Education Program. ATP III Guidelines At-AGlance: Quick Desk Reference. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2001: 1.
34. Wai C-T, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518.
35. Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: Comparison of MR elastography and diffusion-weighted imaging. Am J Roentgenol 2011; 196: 553.
36. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009; 49: 1335.